• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过调控 VEGF/VEGFR2 信号通路研究两种混合配体铜(Ⅱ)配合物的合成、表征及抗肿瘤活性

Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathway.

机构信息

College of Pharmacy, Guilin Medical University, Guangxi Guilin, 541004, China.

出版信息

Dalton Trans. 2017 Dec 21;46(47):16446-16454. doi: 10.1039/c7dt03242k. Epub 2017 Nov 16.

DOI:10.1039/c7dt03242k
PMID:29143014
Abstract

The single crystals of two novel mixed-ligand copper(ii)-based complexes were obtained and characterized. These complexes can remarkably induce apoptosis, inhibit proliferation, suppress migration and metastasis, and inhibit angiogenesis to inhibit the growth of cervical cancer by down-regulating the expressions of the important proteins FAK, Akt and Erk1/2 or their phosphorylated proteins p-FAK, p-Akt, and p-Erk1/2 downstream of the VEGF/VEGFR2 signaling pathway.

摘要

两种新型混合配体铜(II)基配合物的单晶已被获得并进行了表征。这些配合物可以通过下调 VEGF/VEGFR2 信号通路下游的重要蛋白 FAK、Akt 和 Erk1/2 或其磷酸化蛋白 p-FAK、p-Akt 和 p-Erk1/2 的表达,显著诱导细胞凋亡、抑制增殖、抑制迁移和转移,并抑制血管生成,从而抑制宫颈癌的生长。

相似文献

1
Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathway.通过调控 VEGF/VEGFR2 信号通路研究两种混合配体铜(Ⅱ)配合物的合成、表征及抗肿瘤活性
Dalton Trans. 2017 Dec 21;46(47):16446-16454. doi: 10.1039/c7dt03242k. Epub 2017 Nov 16.
2
Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitro.两种新型手性四核铜基配合物:晶体结构、纳米颗粒,以及通过调节 VEGF/VEGFR2 信号通路在体外抑制血管生成和人乳腺癌的生长。
Dalton Trans. 2020 May 14;49(18):6043-6055. doi: 10.1039/d0dt00380h. Epub 2020 Apr 22.
3
Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.混合配体单核铜(II)配合物:晶体结构与抗癌活性
ChemMedChem. 2014 Aug;9(8):1665-71. doi: 10.1002/cmdc.201402060. Epub 2014 May 19.
4
Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.具有吡唑并苯并咪唑配体的细胞毒钌(II)配合物可抑制 VEGFR2 磷酸化。
Inorg Chem. 2021 Dec 6;60(23):18379-18394. doi: 10.1021/acs.inorgchem.1c02979. Epub 2021 Nov 15.
5
A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth and by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors.一种新型手性恶唑啉铜(II)配合物通过调节 VEGF/VEGFR2 下游信号通路和凋亡因子抑制卵巢癌细胞生长。
Dalton Trans. 2023 Aug 22;52(33):11427-11440. doi: 10.1039/d3dt01648j.
6
Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.单核混合配体铜(II)苯氧酸盐配合物介导的高效 DNA 切割:共配体平面性对 DNA 结合和切割以及抗癌活性的影响。
J Inorg Biochem. 2012 Sep;114:94-105. doi: 10.1016/j.jinorgbio.2012.04.018. Epub 2012 May 8.
7
Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.基于铜(II)配合物的碳硅烷金属树状大分子:合成、EPR 特征及抗癌活性。
J Inorg Biochem. 2017 Dec;177:211-218. doi: 10.1016/j.jinorgbio.2017.09.023. Epub 2017 Sep 27.
8
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes.合成、化学表征及 Cu(ii)和 Ru(iii)脂肪族和芳香族二硫代氨基甲酸盐配合物的癌细胞生长抑制活性。
Dalton Trans. 2018 Nov 21;47(43):15477-15486. doi: 10.1039/c8dt02965b. Epub 2018 Oct 18.
9
Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.硒代二唑衍生物通过抑制 VEGFR2 介导的 ERK 和 AKT 信号通路抑制血管生成介导的人乳腺癌肿瘤生长。
Chem Asian J. 2018 Jun 4;13(11):1447-1457. doi: 10.1002/asia.201800110. Epub 2018 May 8.
10
Anti-cancer activities of metal-based complexes by regulating the VEGF/VEGFR2 signaling pathway and apoptosis-related factors Bcl-2, Bax, and caspase-9 to inhibit angiogenesis and induce apoptosis.通过调控 VEGF/VEGFR2 信号通路和凋亡相关因子 Bcl-2、Bax、caspase-9,抑制血管生成并诱导细胞凋亡,发挥金属基配合物的抗癌活性。
Metallomics. 2020 Jan 29;12(1):92-103. doi: 10.1039/c9mt00248k.

引用本文的文献

1
Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development.与帕金森病表型发展风险升高相关的铜状态异常。
Antioxidants (Basel). 2023 Aug 22;12(9):1654. doi: 10.3390/antiox12091654.
2
Transition Metal Complexes with Tridentate Schiff Bases (O N O and O N N) Derived from Salicylaldehyde: An Analysis of Their Potential Anticancer Activity.含三齿席夫碱(O N O 和 O N N)的过渡金属配合物:其抗癌活性分析。
ChemMedChem. 2022 Oct 19;17(20):e202200367. doi: 10.1002/cmdc.202200367. Epub 2022 Sep 23.
3
Tetranuclear Cu(ii)-chiral complexes: synthesis, characterization and biological activity.
四核铜(II)-手性配合物:合成、表征及生物活性
RSC Adv. 2019 Aug 2;9(42):24087-24091. doi: 10.1039/c9ra03586a.
4
Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.四甲基菲咯啉铜配合物在癌症治疗药物研发中的应用:一系列铜(II)-L-二肽-3,4,7,8-四甲基菲咯啉配合物的合成、表征和细胞毒性研究。
J Biol Inorg Chem. 2022 Aug;27(4-5):431-441. doi: 10.1007/s00775-022-01938-3. Epub 2022 May 7.
5
Epithelial-mesenchymal transition and metastasis of colon cancer cells induced by the FAK pathway in cancer-associated fibroblasts.癌症相关成纤维细胞中FAK通路诱导结肠癌细胞的上皮-间质转化和转移
J Int Med Res. 2020 Jun;48(6):300060520931242. doi: 10.1177/0300060520931242.